The information on this page is for informational purposes only and does not constitute medical advice. Consult your genetic counselor or specialist physician for treatment decisions.

TNXB

—Tenascin XB

Chromosome: 6

Location: 6:32041153-32115334

OMIM: 600985

Ensembl: ENSG00000168477

Official·OMIM:600985 Official·ENSG00000168477

Encodes tenascin-X protein. Mutations cause Ehlers-Danlos hypermobility type.

Treatment Roadmap — TNXB

Preclinical

Phase 1

Phase 2

1 trial

Phase 3

Approved

Clinical trials have approximately 10% success rate. This roadmap shows the current status, not guaranteed outcomes.

Associated Diseases

Ehlers-Danlos Syndrome (Hypermobility Type)

Autosomal RecessivePrevalence: 1/5000connective_tissue

Official·OMIM:130020 Official·ORPHA285

Summary

Clinical Trial

Approved Therapy

Registered Variant